2013 Tuberculosis Drug Development GRC

描述(由申请人提供)：本申请寻求对2013年戈登结核病(TB)药物开发研究会议(GRC)的部分支持，会议将于2013年7月21-26日在意大利Il Ciocco举行。这个两年一度的会议是最重要的全球会议，汇聚了学术界和工业界的研究人员，共同关注这一问题。结核病的治疗仍然是一项持续的挑战，特别是在抗药性问题日益严重的情况下。新的治疗方法可以极大地改善药物敏感和耐药疾病的治疗结果，因此人们正在积极寻找具有新作用模式的化合物。结核病药物发现是一个极其活跃的研究领域，越来越多地吸引着具有不同背景的研究人员，包括微生物学、化学、药理学、医学和临床研究。关于结核病药物开发的20113届全球研究报告将为新的研究人员提供一个机会，让他们了解该领域的挑战，并让经验丰富的研究人员在一个特别关键的问题上讨论最新发现 紧要关头。

DESCRIPTION (provided by applicant): This application seeks partial support for the 2013 Gordon Research Conference (GRC) on Tuberculosis (TB) Drug Development to be held in Il Ciocco, Italy from July 21-26, 2013. This biennial event is the most important global conference bringing together researchers from both academia and industry to focus on this problem. Treatment of TB remains a continuing challenge particularly with the increasing problem of drug resistance. New treatments could dramatically improve the results of therapy of both drug-sensitive and drug-resistant disease and compounds with new modes-of-action are being actively sought for this reason. TB drug discovery is an extremely vigorous area of research and is increasingly attracting investigators with diverse backgrounds, including microbiology, chemistry, pharmacology, medicine and clinical research. The 20113 GRC on TB Drug Development will provide an opportunity for new investigators to understand the challenges in the field and for experienced researchers to discuss the latest findings at a particularly critical juncture.